Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19

[1]  X. Chen,et al.  Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium , 2022, Bioengineered.

[2]  S. Paludan,et al.  Innate immunological pathways in COVID-19 pathogenesis , 2022, Science Immunology.

[3]  A. Terentjeva,et al.  Correction to: Replication of LZTFL1 Gene Region as a Susceptibility Locus for COVID-19 in Latvian Population , 2021, Virologica Sinica.

[4]  M. Buti,et al.  Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. , 2021, The Journal of clinical investigation.

[5]  P. Kremsner,et al.  Host genetic factors determining COVID-19 susceptibility and severity , 2021, EBioMedicine.

[6]  J. Todd,et al.  Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus , 2021, Nature Genetics.

[7]  G. Barsh,et al.  Genetic regulation of OAS1 nonsense-mediated decay underlies association with risk of severe COVID-19 , 2021, medRxiv.

[8]  Dan Liu,et al.  Genetic Risk and Chronic Obstructive Pulmonary Disease Independently Predict the Risk of Incident Severe COVID-19 , 2021, Annals of the American Thoracic Society.

[9]  M. Kreuter,et al.  Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs , 2021, Cellular and Molecular Life Sciences.

[10]  K. Bhaskaran,et al.  Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform , 2021, The Lancet.

[11]  Ruth I. Tennen,et al.  Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity , 2021, Nature Genetics.

[12]  A. Koçyiğit,et al.  Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2–infected patients , 2021, Science progress.

[13]  D. H. Farkas,et al.  Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity , 2021, JAMA network open.

[14]  P. Kremsner,et al.  Genomic surveillance of SARS-CoV-2 in the Republic of Congo , 2021, International Journal of Infectious Diseases.

[15]  Mattia G. Bergomi,et al.  Mapping the human genetic architecture of COVID-19 , 2021, Nature.

[16]  G. Dite,et al.  Development and validation of a clinical and genetic model for predicting risk of severe COVID-19 , 2021, Epidemiology and Infection.

[17]  K. Schenke-Layland,et al.  Immune response to SARS-CoV-2 variants of concern in vaccinated individuals , 2021, Nature Communications.

[18]  S. Yazar,et al.  Genetic and epigenetic factors associated with increased severity of Covid‐19 , 2021, Cell biology international.

[19]  Y. Kuroiwa,et al.  Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology , 2021, Journal of clinical medicine.

[20]  P. Kremsner,et al.  Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients , 2021, The American journal of tropical medicine and hygiene.

[21]  M. Hotopf,et al.  Genetic risk for severe COVID‐19 correlates with lower inflammatory marker levels in a SARS‐CoV‐2‐negative cohort , 2021, Clinical & translational immunology.

[22]  Alexander Hanbo Li,et al.  Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease , 2020, medRxiv.

[23]  A. Adegnika,et al.  Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[24]  M. Nöthen,et al.  Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany , 2020, Nature Communications.

[25]  Eurie L. Hong,et al.  AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci , 2020, medRxiv.

[26]  Zhènglì Shí,et al.  Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.

[27]  Lars G. Fritsche,et al.  Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System , 2020, JAMA network open.

[28]  Barbara B. Shih,et al.  Genetic mechanisms of critical illness in COVID-19 , 2020, Nature.

[29]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[30]  K. Brennand,et al.  Common genetic variation in humans impacts in vitro susceptibility to SARS-CoV-2 infection , 2020, bioRxiv.

[31]  A. Doria,et al.  Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[32]  Benoit Morel,et al.  Phylogenetic Analysis of SARS-CoV-2 Data Is Difficult , 2020, bioRxiv.

[33]  K. Fairman.  COVID-19 Infection Fatality Rates. , 2020, Health affairs.

[34]  Edward C. Holmes,et al.  A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.

[35]  R. Kennedy,et al.  The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity , 2020, Immunological reviews.

[36]  S. Rowland-Jones,et al.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.

[37]  D. Melzer,et al.  ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank , 2020, medRxiv.

[38]  J. Erdmann,et al.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.

[39]  Mike Clarke,et al.  A minimal common outcome measure set for COVID-19 clinical research , 2020, The Lancet Infectious Diseases.

[40]  W. Wang,et al.  Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.

[41]  G. Meyerowitz-Katz,et al.  A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates , 2020, International Journal of Infectious Diseases.

[42]  G. Soraya,et al.  Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia , 2020, Medicina Clínica.

[43]  T. Velavan,et al.  Mild versus severe COVID-19: Laboratory markers , 2020, International Journal of Infectious Diseases.

[44]  Amber Dance.  What is a cytokine storm? , 2020 .

[45]  Dong Yang,et al.  Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  M. Nishimura,et al.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.

[47]  T. Velavan,et al.  The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.

[48]  P. Bork,et al.  Interactive Tree Of Life (iTOL) v4: recent updates and new developments , 2019, Nucleic Acids Res..

[49]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[50]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[51]  W. Liu,et al.  Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection , 2015, Journal of Infection.

[52]  S. Amini,et al.  Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of Interferon and Cytokine Research.

[53]  T. Tabuchi,et al.  Coronavirus Disease , 2021, Encyclopedia of the UN Sustainable Development Goals.

[54]  D. A. Jackson,et al.  Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.